Suppr超能文献

具有不同组织学模式的乳头状甲状腺癌。

Papillary thyroid carcinoma with different histological patterns.

作者信息

Lin Jen-Der, Hsueh Chuen, Huang Bie-Yu

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.

出版信息

Chang Gung Med J. 2011 Jan-Feb;34(1):23-34.

Abstract

Tumor-node-metastasis (TNM) staging is the most commonly used model for evaluating therapeutic strategies for papillary thyroid cancer (PTC). Additionally, different histopathological patterns and variants of PTC have been reported to influence the prognosis of these patients. We reviewed the clinical presentation, cancer recurrence, and cancer-specific mortality of the most frequent histological patterns, including the follicular variant (FVPTC), insular pattern, tall cell pattern, diffuse sclerosing type, PTC with Hashimoto's thyroiditis, and multicentric PTC. The tall cell variant of PTC is a more aggressive variant than classical PTC and has a poor prognosis. The high expression of Muc 1 and type IV collagenase in these tumors may facilitate stromal degradation and increase the invasive potential. In contrast, approximately 18% of PTC patients have been identified as having FVPTC. FVPTC patients have a better survival rate than those with follicular thyroid cancer, and fewer instances of lymph node or soft tissue invasion than control patients with classical PTC. The diffuse sclerosing variant of PTC predominantly observed in young patients is a rare aggressive tumor that requires intensive treatment. Despite characteristic clinical and histological features that facilitate easy diagnosis, pre-operative fine needle aspiration cytological diagnosis of this variant is often challenging. Different histological variants of PTC with other histological patterns are important for predicting cancer recurrence. In addition to TNM staging, high-risk histological patterns of PTC require more aggressive follow-up examinations and postoperative adjuvant therapies.

摘要

肿瘤-淋巴结-转移(TNM)分期是评估甲状腺乳头状癌(PTC)治疗策略最常用的模型。此外,据报道,PTC的不同组织病理学模式和变体可影响这些患者的预后。我们回顾了最常见组织学模式的临床表现、癌症复发和癌症特异性死亡率,包括滤泡变体(FVPTC)、岛状模式、高细胞模式、弥漫性硬化型、合并桥本甲状腺炎的PTC以及多中心PTC。PTC的高细胞变体比经典PTC更具侵袭性,预后较差。这些肿瘤中Muc 1和IV型胶原酶的高表达可能促进基质降解并增加侵袭潜力。相比之下,约18%的PTC患者被确定为患有FVPTC。FVPTC患者的生存率高于滤泡状甲状腺癌患者,与经典PTC对照患者相比,淋巴结或软组织侵犯的情况更少。PTC的弥漫性硬化变体主要见于年轻患者,是一种罕见的侵袭性肿瘤,需要强化治疗。尽管其特征性的临床和组织学特征便于诊断,但该变体的术前细针穿刺细胞学诊断往往具有挑战性。PTC与其他组织学模式的不同组织学变体对于预测癌症复发很重要。除TNM分期外,PTC的高危组织学模式需要更积极的随访检查和术后辅助治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验